Tenelia targets the top Januvia by effectiveness comparison
Movements of ‘Tenelia(generic name: teneligliptin),’ a DPP-4 inhibitor launched for the 7th time in the domestic market, have been aggressive. Handok has stressed its goal to name the drug in the ‘Top 3’ by showing its indirect comparison result to ‘Januvia(generic name: sitagliptin).
The compan...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
